ABAndrew Bauerschmidt

Andrew Bauerschmidt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew Bauerschmidt has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Causes and Outcome of Coma: A Nationwide Cross-Sectional Analysis

    by Harli Weber, Aiden K. Lui, Deepika Dilip, Marco Salazar, Gavin Yuan, Julia Zhang, Josef Kusayev, Jon Rosenberg, Andrew Bauerschmidt, Fawaz Al-Mufti, et al.

  • Levetiracetam for Seizure Prophylaxis after Traumatic Brain Injury: A Severity‐Stratified Cohort Study of 51,000 Patients

    by Isaac B. Thorman, Ariel Sacknovitz, Austin G. Li, Aryan Malhotra, Patricia E. McGoldrick, Michael C. Schubert, Carrie R. Muh, Steven M. Wolf, Jon B. Rosenberg, Andrew Bauerschmidt, et al.

    Objectives: The objective of this study was to evaluate the effectiveness and adverse effect profile of prophylactic levetiracetam in preventing epilepsy after traumatic brain injury (TBI). Methods: This retrospective cohort study used the TriNetX Research Network, encompassing >150 million patients. Adults (≥18 years) with a first TBI and Glasgow Coma Scale (GCS) score recorded were included. Patients with pre‐existing epilepsy, seizures on the day of injury, or prior levetiracetam exposure were excluded. The cohort (n = 51,263) was stratified into mild (GCS 13–15; n = 33,625) and severe (GCS 3–8; n = 10,805) TBI. The risk of early (p = 0.04) but not in mild TBI (HR = 0.85, 95% CI = 0.45–1.61, p = 0.61). Levetiracetam did not reduce late epilepsy in either mild (HR = 1.00, 95% CI = 0.79–1.15, p = 0.997) or severe (HR = 0.90, 95% CI = 0.68–1.19, p = 0.45) TBI. Older age, cerebral edema, and subdural hemorrhage were consistent risk factors. Adverse outcomes included impaired memory and awareness, metabolic disorders, and psychiatric symptoms. Interpretation: Levetiracetam prophylaxis reduced early epilepsy only in severe TBI and conferred no long‐term protection. Given its adverse effect burden, routine prophylaxis should be limited to severe TBI or high‐risk patients. These findings support re‐evaluation of current seizure prophylaxis guidelines, which are based on older antiseizure medications and predate large‐scale real‐world data. ANN NEUROL 2026


  • Open Access

    Use of quantitative pupillometry in the neuro intensive care unit setting

    by Alizabeth York, Farial Rahman, Andrew Bauerschmidt

    Since the early second century, the pupillary light response (PLR) has been utilized in neurological examinations to gain insight into patient conditions and neuroprognostication. Traditionally, manual pupillometry has been employed to evaluate PLRs. However, this method is subjective and exhibits low interexaminer consistency and reliability. The advent of quantitative pupillometry (QP) has provided clinicians with an objective and reliable method to evaluate and standardize pupillary metrics, most notably, the Neurological Pupil index (NPi). QP protocols have been instituted in many neuro intensive care units (ICUs) as a tool for quickly assessing patients and informing clinical decision-making. A literature review was conducted to understand the use of QP in neuro ICUs and document the relationships between pupillary measurements and clinical consequences. The databases PubMed, Embase, and Scopus were systematically searched for original research articles from 1995 to 2025 in which QP was used for adult patients in the neuro ICU. Using 21 search terms, a total of 52 articles were identified and analyzed. The findings demonstrated the widespread use of QP in patients with acute brain injuries, such as traumatic brain injury, aneurysmal subarachnoid hemorrhage, intracerebral hemorrhage, and stroke. Many studies have established NPi as a non-invasive surrogate measure of intracranial pressure (ICP), which is particularly useful in screening for elevated ICP owing to its high negative predictive value. Correlations were noted between abnormal NPi, poor neurological outcomes, and a greater risk of mortality in many types of brain injury. The identification of the relationship between NPi and clinical events in specific patient populations may aid clinicians in tailoring QP usage to patients.

  • Ketamine in the Neuro-Intensive Care Unit

    by Andrew Bauerschmidt, Stuart Brill, Jon Rosenberg

  • Open Access

    Exploring the Obesity Paradox in All Subtypes of Intracranial Hemorrhage: A Retrospective Cohort Analysis of 13,000 Patients

    by Helen Ng, Ellen N. Huhulea, Ankita Jain, Michael Fortunato, Galadu Subah, Ariel Sacknovitz, Eris Spirollari, Jon B. Rosenberg, Andrew Bauerschmidt, Stephan A. Mayer, et al.

    Background/Objectives: Recent studies reveal an “obesity paradox”, suggesting better clinical outcomes after intracranial hemorrhage for obese patients compared to patients with a healthy BMI. While this paradox indicates improved survival rates for obese individuals in stroke cases, it is unknown whether this trend remains true across all forms of intracranial hemorrhage. Therefore, the objective of our study was to investigate the incidence, characteristics, and outcomes of hospitalized obese patients with intracranial hemorrhage. Methods: The National Inpatient Sample (NIS) database was queried for data from 2015 to 2019 to identify adult patients aged 18 years and older with a primary diagnosis of non-traumatic intracranial hemorrhage. Using International Classification of Disease 10th Edition codes, patients were stratified by BMI categories: healthy weight, overweight, class I–II obesity, and class III obesity. The cohorts were examined for demographic characteristics, comorbidities, stroke severity, inpatient complications, interventions, and clinical outcomes, including length of stay (LOS), discharge disposition, and inpatient mortality. Results: Of 41,960 intracranial hemorrhage patients identified, 13,380 (33.0%) also had an obese BMI. Class I–II obese intracranial hemorrhage patients were more likely to be of white race (OR: 1.101, 95% CI: 1.052, 1.152, p < 0.001), less likely to be female (OR: 0.773, 95% CI: 0.740, 0.808, p < 0.001), and more likely to have diabetes mellitus (OR: 1.545, 95% CI: 1.477, 1.616, p < 0.001) and hypertension (OR: 1.828, 95% CI: 1.721, 1.943, p < 0.001) in comparison to healthy-weight patients. In a matched cohort analysis adjusting for demographics and severity, intracranial hemorrhage patients with class I–II obesity had a shorter length of stay (LOS) (OR 0.402, 95% CI: 0.118, 0.705, p < 0.001), reduced inpatient mortality (OR 0.847, 95% CI: 0.798, 0.898, p < 0.001), and more favorable discharge disposition (OR 1.395, 95% CI: 1.321, 1.474, p < 0.001) compared to their healthy-weight counterparts. Furthermore, these patients were less likely to require decompressive hemicraniectomy (OR 0.697, 95% CI: 0.593, 0.820, p < 0.001). Following an analysis of individual ICH subtypes, obese subarachnoid hemorrhage (SAH) patients demonstrated reduced mortality (OR: 0.692, 95% CI: 0.577–0.831, p < 0.001) and LOS (OR: 0.070, 95% CI: 0.466–0.660, p = 0.039), with no differences in discharge disposition. Similarly, intracerebral hemorrhage patients demonstrated reduced mortality (OR: 0.891, 95% CI: 0.827–0.959, p = 0.002) and LOS (OR: 0.480, 95% CI: 0.216–0.743, p < 0.001). Other ICH subtypes showed improved discharge outcomes (OR: 1.504, 95% CI: 1.368–1.654, p < 0.001), along with decreased mortality (OR: 0.805, 95% CI: 0.715–0.907, p < 0.001) and LOS (OR: −10.313, 95% CI: −3.599 to −2.449, p < 0.001). Conclusions: Intracranial hemorrhage patients with class I–II obesity exhibited more favorable clinical outcomes than those who were of a healthy weight or overweight. Despite its association with risk factors contributing to intracranial hemorrhage, class I–II obesity was associated with improved outcomes, lending support to the existence of the obesity paradox in stroke.


  • Acute kidney injury in subarachnoid hemorrhage: Exploring its clinical significance and prognostic implications

    by Galadu Subah, Rohan Patel, Bridget Nolan, Michael Fortunato, Aiden Lui, Anaz Uddin, Austin Li, Eris Spirollari, Halla Nuoaman, Yasir Ammar Adnan, et al.


  • Modern Sedation and Analgesia Strategies in Neurocritical Care

    by Andrew Bauerschmidt, Tarik Al-Bermani, Syed Ali, Brittany Bass, Jessica Dorilio, Jon Rosenberg, Fawaz Al-Mufti

    Purpose of Review Patients with acute neurologic injury require a specialized approach to critical care, particularly with regard to sedation and analgesia. This article reviews the most recent advances in methodology, pharmacology, and best practices of sedation and analgesia for the neurocritical care population. Recent Findings In addition to established agents such as propofol and midazolam, dexmedetomidine and ketamine are two sedative agents that play an increasingly central role, as they have a favorable side effect profile on cerebral hemodynamics and rapid offset can facilitate repeated neurologic exams. Recent evidence suggests that dexmedetomidine is also an effective component when managing delirium. Combined analgo-sedation with low doses of short-acting opiates is a preferred sedation strategy to facilitate neurologic exams as well as patient-ventilator synchrony. Summary Optimal care for patients in the neurocritical care population requires an adaptation of general ICU strategies that incorporates understanding of neurophysiology and the need for close neuromonitoring. Recent data continues to improve care tailored to this population.


  • Acute Respiratory Distress Syndrome in Patients with Subarachnoid Hemorrhage: Incidence, Predictive Factors, and Impact on Mortality

    by Eric Feldstein, Syed Ali, Smit Patel, Keshav Raghavendran, Erick Martinez, Leah Blowes, Jonathan Ogulnick, Michelle Bravo, Jose Dominguez, Boyi Li, et al.

    Introduction: Acute respiratory distress syndrome (ARDS) is a known predictor of poor outcomes in critically ill patients. We sought to examine the role ARDS plays in outcomes in subarachnoid hemorrhage (SAH) patients. Prior studies investigating the incidence of ARDS in SAH patients did not control for SAH severity. Hence, we sought to determine the incidence ARDS in patients diagnosed with aneurysmal SAH and investigate the predisposing risk factors and impact upon outcomes. Methods: A retrospective cohort study was conducted using the National Inpatient Sample (NIS) database for the years 2008 to 2014. Multivariate stepwise regression analysis was performed to identify the risk factors and outcome associated with developing ARDS in the setting of SAH. Results: We identified 170,869 patients with non-traumatic subarachnoid hemorrhage, of whom 6962 were diagnosed with ARDS and of those 4829 required mechanical ventilation. ARDS more frequently developed in high grade SAH patients (1.97 ± 0.05 vs. 1.15 ± 0.01; p < 0.0001). Neurologic predictors of ARDS included cerebral edema (OR 1.892, CI 1.180–3.034, p = 0.0035) and medical predictors included cardiac arrest (OR 4.642, CI 2.273–9.482, p < 0.0001) and cardiogenic shock (OR 2.984, CI 1.157–7.696, p = 0.0239). ARDS was associated with significantly worse outcomes (15.5% vs. 52.9% discharged home, 63.0% vs. 40.8% discharged to rehabilitation facility and 21.5% vs. 6.3% in-hospital mortality). Conclusion: Patients with SAH who developed ARDS were less likely to be discharged home, more likely to need rehabilitation and had a significantly higher risk of mortality. The identification of risk factors contributing to ARDS is helpful for improving outcomes and resource utilization.


  • Utility of frailty as a predictor of acute kidney injury in patients with aneurysmal subarachnoid hemorrhage

    by Christina Ng, Jose F Dominguez, Rasheed Hosein-Woodley, Eric Feldstein, Alexandria Naftchi, Aiden Lui, Alis J Dicpinigaitis, Matthew K McIntyre, Gurmeen Kaur, Justin Santarelli, et al.

    Introduction: Acute kidney injury (AKI) is associated with poor outcome in aneurysmal subarachnoid hemorrhage patients (aSAH). Frailty has recently been demonstrated to correlate with elevated mortality and morbidity; its impact on predicting AKI and mortality in aSAH patients has not been investigated. Objective: Evaluating risk factors and predictors for AKI in aSAH patients. Methods: aSAH patients from a single-center's prospectively maintained database were retrospectively evaluated for development of AKI within 14 days of admission. Baseline demographic and clinical characteristics were collected. The effect of frailty and other risk factors were evaluated. Results: Of 213 aSAH patients, 53 (33.1%) were frail and 12 (5.6%) developed AKI. Admission serum creatinine (sCr) and peak sCr within 48 h were higher in frail patients. AKI patients showed a trend towards higher frailty. Mortality was significantly higher in AKI than non-AKI aSAH patients. Frailty was a poor predictor of AKI when controlling for Hunt and Hess (HH) grade or age. HH grade ≥ 4 strongly predicted AKI when controlling for frailty. Conclusion: AKI in aSAH patients carries a poor prognosis. The HH grade appears to have superior utility as a predictor of AKI in aSAH patients than mFI.


  • Predicting early recovery of consciousness after cardiac arrest supported by quantitative electroencephalography

    by Andrew Bauerschmidt, Andrey Eliseyev, Kevin W. Doyle, Angela Velasquez, Jennifer Egbebike, Wendy Chiu, Vedika Kumar, Ayham Alkhachroum, Caroline Der Nigoghossian, Fawaz Al-Mufti, et al.